Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-11, Vol.29, p.ix35-ix36 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | ix36 |
|---|---|
| container_issue | |
| container_start_page | ix35 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Yeh, K.-H. Yang, T.-S. Hsu, T.-C. Chen, W.T.-L. Chen, H.-H. Teng, H.-W. Lin, B.-W. Kuan, F.-C. Chiang, F.-F. Duann, C.-W. Li, Y.-S. Fiala-Buskies, S. Ducreux, M. Wang, J.-Y. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy431.023 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy431_023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419430809</els_id><sourcerecordid>32178000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2783-370f53007fc706d4d4830eae04f0a9fc9ddde86cb30c43948a49d4a828dbcdac3</originalsourceid><addsrcrecordid>eNp9kd1q2zAUx8VYWbN2D7CbcS43mFvZUmJruwomWwuBQsiujSwdtRq2ZCQnwe-4h5qMt13uSkj_j3PQj5D3Ob3LqWD30jnv1H2vJ87yO1qwV2SVrzciqyjPX5MVFQXLyjXj1-RtjD8ppRtRiDfkmhV5WaXrivw6oOyyiw-dBjxbjU4heAPjC0KUBscJpEuSMahGe0aHMc56wGcfku5sC9bBIEeLboxwseML9DjKOKYnBcp3PqSo7EDJ1B3gY18f6k9ggu_hKO1Fui-whXhqn4M_DWma7KZo42KY1xiCj8My_TP4NmI4p2qffFA_HQ67_fa4gzie9HRLrozsIr77c96QH992x_oh2z99f6y3-0wVZcUyVlKzZpSWRpV0o7nmFaMokXJDpTBKaK2x2qiWUcWZ4JXkQnNZFZVulZaK3ZB86VVptRjQNEOwvQxTk9NmJtMsZJqFTJPIpMyHJTOc2h71v8RfFMnwdTFg2vxsMTRR2RmHtvMHNtrb_9T_BrtEpk0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yeh, K.-H. ; Yang, T.-S. ; Hsu, T.-C. ; Chen, W.T.-L. ; Chen, H.-H. ; Teng, H.-W. ; Lin, B.-W. ; Kuan, F.-C. ; Chiang, F.-F. ; Duann, C.-W. ; Li, Y.-S. ; Fiala-Buskies, S. ; Ducreux, M. ; Wang, J.-Y.</creator><creatorcontrib>Yeh, K.-H. ; Yang, T.-S. ; Hsu, T.-C. ; Chen, W.T.-L. ; Chen, H.-H. ; Teng, H.-W. ; Lin, B.-W. ; Kuan, F.-C. ; Chiang, F.-F. ; Duann, C.-W. ; Li, Y.-S. ; Fiala-Buskies, S. ; Ducreux, M. ; Wang, J.-Y.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy431.023</identifier><identifier>PMID: 32178000</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-11, Vol.29, p.ix35-ix36</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2783-370f53007fc706d4d4830eae04f0a9fc9ddde86cb30c43948a49d4a828dbcdac3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32178000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yeh, K.-H.</creatorcontrib><creatorcontrib>Yang, T.-S.</creatorcontrib><creatorcontrib>Hsu, T.-C.</creatorcontrib><creatorcontrib>Chen, W.T.-L.</creatorcontrib><creatorcontrib>Chen, H.-H.</creatorcontrib><creatorcontrib>Teng, H.-W.</creatorcontrib><creatorcontrib>Lin, B.-W.</creatorcontrib><creatorcontrib>Kuan, F.-C.</creatorcontrib><creatorcontrib>Chiang, F.-F.</creatorcontrib><creatorcontrib>Duann, C.-W.</creatorcontrib><creatorcontrib>Li, Y.-S.</creatorcontrib><creatorcontrib>Fiala-Buskies, S.</creatorcontrib><creatorcontrib>Ducreux, M.</creatorcontrib><creatorcontrib>Wang, J.-Y.</creatorcontrib><title>Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kd1q2zAUx8VYWbN2D7CbcS43mFvZUmJruwomWwuBQsiujSwdtRq2ZCQnwe-4h5qMt13uSkj_j3PQj5D3Ob3LqWD30jnv1H2vJ87yO1qwV2SVrzciqyjPX5MVFQXLyjXj1-RtjD8ppRtRiDfkmhV5WaXrivw6oOyyiw-dBjxbjU4heAPjC0KUBscJpEuSMahGe0aHMc56wGcfku5sC9bBIEeLboxwseML9DjKOKYnBcp3PqSo7EDJ1B3gY18f6k9ggu_hKO1Fui-whXhqn4M_DWma7KZo42KY1xiCj8My_TP4NmI4p2qffFA_HQ67_fa4gzie9HRLrozsIr77c96QH992x_oh2z99f6y3-0wVZcUyVlKzZpSWRpV0o7nmFaMokXJDpTBKaK2x2qiWUcWZ4JXkQnNZFZVulZaK3ZB86VVptRjQNEOwvQxTk9NmJtMsZJqFTJPIpMyHJTOc2h71v8RfFMnwdTFg2vxsMTRR2RmHtvMHNtrb_9T_BrtEpk0</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Yeh, K.-H.</creator><creator>Yang, T.-S.</creator><creator>Hsu, T.-C.</creator><creator>Chen, W.T.-L.</creator><creator>Chen, H.-H.</creator><creator>Teng, H.-W.</creator><creator>Lin, B.-W.</creator><creator>Kuan, F.-C.</creator><creator>Chiang, F.-F.</creator><creator>Duann, C.-W.</creator><creator>Li, Y.-S.</creator><creator>Fiala-Buskies, S.</creator><creator>Ducreux, M.</creator><creator>Wang, J.-Y.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201811</creationdate><title>Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study</title><author>Yeh, K.-H. ; Yang, T.-S. ; Hsu, T.-C. ; Chen, W.T.-L. ; Chen, H.-H. ; Teng, H.-W. ; Lin, B.-W. ; Kuan, F.-C. ; Chiang, F.-F. ; Duann, C.-W. ; Li, Y.-S. ; Fiala-Buskies, S. ; Ducreux, M. ; Wang, J.-Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2783-370f53007fc706d4d4830eae04f0a9fc9ddde86cb30c43948a49d4a828dbcdac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeh, K.-H.</creatorcontrib><creatorcontrib>Yang, T.-S.</creatorcontrib><creatorcontrib>Hsu, T.-C.</creatorcontrib><creatorcontrib>Chen, W.T.-L.</creatorcontrib><creatorcontrib>Chen, H.-H.</creatorcontrib><creatorcontrib>Teng, H.-W.</creatorcontrib><creatorcontrib>Lin, B.-W.</creatorcontrib><creatorcontrib>Kuan, F.-C.</creatorcontrib><creatorcontrib>Chiang, F.-F.</creatorcontrib><creatorcontrib>Duann, C.-W.</creatorcontrib><creatorcontrib>Li, Y.-S.</creatorcontrib><creatorcontrib>Fiala-Buskies, S.</creatorcontrib><creatorcontrib>Ducreux, M.</creatorcontrib><creatorcontrib>Wang, J.-Y.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeh, K.-H.</au><au>Yang, T.-S.</au><au>Hsu, T.-C.</au><au>Chen, W.T.-L.</au><au>Chen, H.-H.</au><au>Teng, H.-W.</au><au>Lin, B.-W.</au><au>Kuan, F.-C.</au><au>Chiang, F.-F.</au><au>Duann, C.-W.</au><au>Li, Y.-S.</au><au>Fiala-Buskies, S.</au><au>Ducreux, M.</au><au>Wang, J.-Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-11</date><risdate>2018</risdate><volume>29</volume><spage>ix35</spage><epage>ix36</epage><pages>ix35-ix36</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32178000</pmid><doi>10.1093/annonc/mdy431.023</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-11, Vol.29, p.ix35-ix36 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy431_023 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | Real-world evidence of the safety and effectiveness of regorafenib in patients with metastatic colorectal cancer (mCRC) from Taiwan: A subgroup analysis from the prospective, observational CORRELATE study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T03%3A04%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Real-world%20evidence%20of%20the%20safety%20and%20effectiveness%20of%20regorafenib%20in%20patients%20with%20metastatic%20colorectal%20cancer%20(mCRC)%20from%20Taiwan:%20A%20subgroup%20analysis%20from%20the%20prospective,%20observational%20CORRELATE%20study&rft.jtitle=Annals%20of%20oncology&rft.au=Yeh,%20K.-H.&rft.date=2018-11&rft.volume=29&rft.spage=ix35&rft.epage=ix36&rft.pages=ix35-ix36&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy431.023&rft_dat=%3Cpubmed_cross%3E32178000%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32178000&rft_els_id=S0923753419430809&rfr_iscdi=true |